Product
KK2260
1 clinical trial
1 indication
Indication
Advanced or Metastatic Solid TumorsClinical trial
A Phase 1, Uncontrolled, Open-label, Non-randomized, Dose-escalation Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors, Followed by an Uncontrolled, Randomized Study in Patients With Esophageal Cancer or Head and Neck Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2028-11-30